Spruce Biosciences, Inc. (SPRB)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.4577 |
| Open | 0.4698 |
| Bid | 0.3255 x 200 |
| Ask | 0.5980 x 200 |
| Day's range | 0.4537 - 0.4713 |
| 52-week range | 0.4110 - 5.9500 |
| Volume | |
| Avg. volume | 429,195 |
| Market cap | 19.218M |
| Beta (5Y monthly) | 2.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates
Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 33.33% and 3.87%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 12.50% and 79.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know
Spruce Biosciences (SPRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.